fibrinogen has been researched along with Heart Valve Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (42.86) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ahangar, H; Bassiri, HA; Gohari, S; Noohi Bezanjani, F; Reshadmanesh, T | 1 |
| Litt, H; Mohamed, BA; Rosas, SE; Yang, W | 1 |
| Astarcioğlu, MA; Aykan, AC; Bayram, Z; Ertürk, E; Gökdeniz, T; Gündüz, S; Gürsoy, OM; Kalçik, M; Karakoyun, S; Oğuz, AE; Ozkan, M | 1 |
| Baker, WL; Chen, WT; Colby, JA; Coleman, CI; Kluger, J; Reinhart, K; White, CM | 1 |
| Afonso, A; Lin, HM; Neckman, D; Raikhelkar, J; Scurlock, C | 1 |
| Ait Houssa, M; Amahzoune, B; Arji, M; Azendour, H; Boulahya, A; Elbekkali, Y; Elkirat, A; Ibbat, D; Jabrani, K; Mamoun, F; Selkane, C; Wahid, FA | 1 |
| Akimoto, H; Baba, S; Fukuchi, M; Kagaya, Y; Kumagai, K; Oda, K; Ohta, J; Shirato, K; Tabayashi, K; Watanabe, J | 1 |
| Kristensen, AT; Olsen, LH; Pedersen, HD; Tarnow, I | 1 |
| Adam, FU; Baltali, M; Erdem, A; Haberal, M; Ozdemir, FN; Sezer, S; Torun, D | 1 |
| Davies, GC; Salzman, EW; Sobel, M | 1 |
| Loeliger, EA | 1 |
| Acar, J; Dumoulin, M; Horellou, MH; Samama, M; Tirmarche, M | 1 |
| Banyai, M; Ehringer, H; Haumer, M; Koppensteiner, R; Moidl, R; Moritz, A; Wolner, E | 1 |
| Song, Z; Stammers, AH; Wang, C | 1 |
| Blann, AD; Goldsmith, IR; Lip, GY; Patel, RL | 1 |
| Bernhard, A; Harke, H; Schwarze, EW; Stambolis, C | 1 |
| Collet, H; Littleton, P; Marshall, J; McDonald, L; Tessier, Y | 1 |
| Ashburn, WL; Kramer, RS; Morrow, AG; Vasko, JS | 1 |
| Dutton, RC; Edmunds, LH; Hutchinson, JC; Roe, BB | 1 |
| Gudenko, VV; Radzivil, GG; Solov'ev, GM | 1 |
| Thurnherr, N | 1 |
3 trial(s) available for fibrinogen and Heart Valve Diseases
| Article | Year |
|---|---|
Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery.
Topics: Aged; Ascorbic Acid; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Female; Fibrinogen; Heart Valve Diseases; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Vitamins | 2011 |
Clinical comparison of pulsatile and nonpulsatile perfusion during cardiopulmonary bypass.
Topics: Adult; Aortic Valve; Cardiopulmonary Bypass; Evaluation Studies as Topic; Female; Fibrinogen; Heart; Heart Defects, Congenital; Heart Valve Diseases; Hemoglobins; Humans; Kidney; Male; Mitral Valve; Myocardial Contraction; Platelet Count; Prospective Studies; Pulsatile Flow; Rheology; Skin Temperature; Treatment Outcome; Urine | 1997 |
Plasma-fibrinogen after replacement of heart valves by grafts and prostheses.
Topics: Adult; Age Factors; Aged; Animals; Dogs; Fascia; Fibrinogen; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valves; Hematocrit; Humans; Middle Aged; Rabbits; Time Factors; Transplantation, Autologous; Transplantation, Homologous | 1971 |
18 other study(ies) available for fibrinogen and Heart Valve Diseases
| Article | Year |
|---|---|
Risk Factors Associated with Heart Valve Thrombosis in Patients with Prosthetic Heart Valve Dysfunction.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Cross-Sectional Studies; Female; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Iran; Logistic Models; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombosis | 2020 |
Valvular calcification, inflammation, and mortality in dialysis patients.
Topics: Adult; Aged; alpha-2-HS-Glycoprotein; Calcinosis; Coronary Vessels; Female; Fibrinogen; Heart Valve Diseases; Heart Valves; Humans; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Regression Analysis; Renal Dialysis; Statistics as Topic; Survival Analysis; United States | 2013 |
Value of serum fibrinogen levels in the assessment of mechanical prosthetic valve thrombosis.
Topics: Adult; Anticoagulants; Biomarkers; Case-Control Studies; Echocardiography, Transesophageal; Female; Fibrinogen; Heart Atria; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Risk Factors; Thrombosis; Up-Regulation; Ventricular Function, Left | 2014 |
Isolated tricuspid valve surgery: predictors of adverse outcome and survival.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Erythrocyte Transfusion; Factor VIII; Female; Fibrinogen; Heart Valve Diseases; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Transfusion; Proportional Hazards Models; Prosthesis Implantation; Respiration, Artificial; Retrospective Studies; Risk Factors; Survival Rate; Tricuspid Valve; Young Adult | 2013 |
[Tranexamic acid versus aprotinin for the prevention of bleeding during mitral valve surgery ].
Topics: Adult; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiopulmonary Bypass; Dose-Response Relationship, Drug; Female; Fibrinogen; Heart Valve Diseases; Hemostatics; Humans; Male; Mitral Valve; Platelet Count; Retrospective Studies; Tranexamic Acid; Treatment Outcome | 2003 |
Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling.
Topics: Adult; Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Atrial Function; Endocardium; Female; Fibrin; Fibrinogen; Gene Expression; Heart Atria; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Messenger; Thrombophilia; von Willebrand Factor | 2004 |
Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Topics: Animals; Biomarkers; Dog Diseases; Dogs; Electrocardiography; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Heart Valve Diseases; Hemostasis; Male; Mitral Valve; Mitral Valve Insufficiency; Partial Thromboplastin Time; Prothrombin Time; von Willebrand Factor | 2004 |
Association of cardiac valve calcification and inflammation in patients on hemodialysis.
Topics: Age Factors; C-Reactive Protein; Calcinosis; Echocardiography; Female; Fibrinogen; Heart Valve Diseases; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Time Factors | 2005 |
Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.
Topics: Adult; Cardiopulmonary Bypass; Coronary Artery Bypass; Fibrinogen; Fibrinopeptide A; Heart Valve Diseases; Hematocrit; Humans; Platelet Count; Radioimmunoassay; Thromboxane B2; Thromboxanes | 1980 |
Platelets, cardiac valves and sulphinpyrazone.
Topics: Blood Platelets; Fibrinogen; Heart Valve Diseases; Humans; Sulfinpyrazone | 1982 |
Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement.
Topics: Adolescent; Adult; Aged; Aortic Valve; Blood Platelets; Cell Survival; Child; Female; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Megakaryocytes; Middle Aged; Mitral Valve | 1981 |
Blood rheology in patients with native heart valve disease and after valve replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Viscosity; Echocardiography; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Postoperative Complications; Thrombosis | 1998 |
Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
Topics: Aged; Aortic Valve; Endothelium, Vascular; Female; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Risk Factors; Thromboembolism; von Willebrand Factor | 2001 |
[The influence of increased clotting reactions as shown by thrombosis formation in the immediate postoperative period on aortic valve prothesis (author's transl)].
Topics: Aortic Valve; Blood Cell Count; Blood Coagulation; Blood Platelets; Extracorporeal Circulation; Factor V; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Prothrombin; Thromboplastin; Thrombosis; Time Factors | 1975 |
Detection of intracardiac thrombi using radio-iodinated antifibrinogen (RIAF) and precordial scanning: experimental and clinical studies.
Topics: Adult; Animals; Antibodies; Autoradiography; Chlormerodrin; Dogs; Fibrinogen; gamma-Globulins; Gastric Juice; Heart Aneurysm; Heart Atria; Heart Valve Diseases; Humans; Iodine Radioisotopes; Male; Myocardium; Radiometry; Sclerosing Solutions; Serum Albumin, Radio-Iodinated; Thrombosis | 1967 |
Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Platelets; Embolism; Extracorporeal Circulation; Female; Fibrinogen; Heart Valve Diseases; Heart, Artificial; Hematocrit; Humans; Male; Micropore Filters; Middle Aged; Oxygenators; Oxygenators, Membrane; Platelet Adhesiveness; Polyurethanes; Stainless Steel | 1974 |
[Rheologic properties of blood in cardiac surgery].
Topics: Blood Flow Velocity; Blood Proteins; Blood Viscosity; Cardiac Surgical Procedures; Extracorporeal Circulation; Fibrinogen; Heart Defects, Congenital; Heart Valve Diseases; Heart Valve Prosthesis; Hematocrit; Humans; Postoperative Complications; Time Factors | 1971 |
Blood coagulation studies and extracorporeal circulation in man.
Topics: Adult; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Child; Clot Retraction; Extracorporeal Circulation; Fibrinogen; Fibrinolysis; Heart Defects, Congenital; Heart Valve Diseases; Heparin; Humans; Protamines; Prothrombin Time | 1967 |